Nicoya Lifesciences raises $2 million to make protein testing equipment more accessible to researchers

Funding Rounds

▤ Summary

The funding was led by Ripple Ventures and GTAN, with participation from MaRS IAF, BDC, Garage Capital, Angel One, Maple Leaf Angels, Innovation Grade Ventures, the Laurier Startup Fund, the University of Waterloo Student Venture Fund and the Waterloo Alumni Angels. “We are developing some of the most advanced biosensor technologies in the world and we are excited about the impact they will have on human health in the future," said Ryan Denomme, Nicoya Lifesciences co-founder and CEO. Nicoya received $50,000 from the Communitech Rev Awards in September 2015. “The entire Nicoya team have built a product that lets academic and private institutions run tests at a fraction of the cost,” said Matt Cohen, managing partner of Ripple Ventures. “We are confident that their data-driven sales strategy will accelerate their time to market and quickly disrupt the fragmented SPR industry.

$ Funding

$
Amount $2.0M Total raised
□
Date January 29, 2018 Announcement date
◎
Investors NorthSpring Capital Partners, Innovation Grade Ventures, Maple Leaf Angels, Angel One Network, MaRS Investment Accelerator Fund Lead investors
▥
Company http://www.nicoyalife.com Funded company

▥ Classifications

industries
No industries detected
applications
Accounting and Taxes

◇ AskAI Classifications

Labels
Scientific Instrumentation Software Biotechnology Software SaaS for Scientific Research

▦ Linked Companies